HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Anthony J. Tortolani Leonard Y. Lee Permission Requests Citing Articles Citing Articles via HighWire Google Scholar Articles by Tavakol, M. Articles by Heitner, J. F. PubMed Articles by Tavakol, M. Articles by Heitner, J. F. Related Collections Electrophysiology - arrhythmias Related Article

---

Original Articles: Adult Cardiac

Utility of Brain Natriuretic Peptide as a Predictor of Atrial Fibrillation After Cardiac Operations

^a Division of Cardiology, Department of Medicine, New York Methodist Hospital, Brooklyn, New York
^b Department of Statistics, New York Methodist Hospital, Brooklyn, New York
^c Department of Cardiothoracic Surgery, New York Methodist Hospital, Brooklyn, New York
^d Department of Cardiothoracic Surgery, Weill Medical College of Cornell University, New York, New York

Accepted for publication April 6, 2009.

^_* Address correspondence to Dr Tavakol, Research Fellow, New York Methodist Hospital, Department of Cardiology, Division of Medicine, 506 6th St, 2nd Floor, Division of Cardiology, Brooklyn, NY 11215 (Email: motavakol{at}yahoo.com).

Background: Atrial fibrillation (AF) occurs frequently after coronary bypass grafting and valve operations. Brain natriuretic peptide (BNP) has been shown to predict recurrence of AF in congestive heart failure. It is a potential biomarker for preoperative risk stratification for development of AF in at-risk patients.

Methods: A total of 398 consecutive patients were prospectively evaluated for new-onset AF after heart operations. Patients with a history of AF and presence of permanent pacemaker were excluded. BNP levels were measured before and immediately after the operation.

Results: AF occurred in 20%. AF was more likely to develop in patients who were older, who underwent valve operations, had a lower ejection fraction, and a larger left atrial size. Preoperative exposure to statins (62% vs 43%, p < 0.01) and angiotensin inhibitors (60% vs 45%, p = 0.02) was more common in patients without AF. BNP values were insignificantly higher preoperatively (361 vs 302 mg/dL, p = 0.3) and postoperatively (312 vs. 229 mg/dL, p = 0.15) in patients with AF. Multivariate logistic analysis showed that older age (odds ratio [OR], 3.1, 95% confidence interval [CI], 1.7 to 5.6), lower ejection fraction (OR, 2.0; 95% CI, 1.2 to 3.3), larger left atrial size (OR, 3.1; 95% CI, 1.9 to 4.9), and nonuse of angiotensin inhibitors (OR, 2.3; 95% CI, 1.1 to 4.8) were independently associated with AF.

Conclusions: This study does not support use of BNP for prediction of AF. Age, low ejection fraction, large left atrial size, and nonuse of angiotensin blocking agents were found to be significant predictors of AF development.

Related Article

Invited Commentary

Stuart P. Thomas
Ann. Thorac. Surg. 2009 88: 807-808. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

				S. P. Thomas Invited commentary. Ann. Thorac. Surg., September 1, 2009; 88(3): 807 - 808. [Full Text] [PDF]